Leadership Overview
AxoGen has 4 executives leading key functions including strategy, finance, marketing, and medical affairs.
Driven by innovation in surgical solutions, AxoGen is dedicated to advancing the repair and regeneration of peripheral nerve injuries, impacting patient outcomes globally.
Driven by innovation in surgical solutions, AxoGen is dedicated to advancing the repair and regeneration of peripheral nerve injuries, impacting patient outcomes globally.
Leadership Roles at AxoGen
Karen Zaderej - President, Chief Executive Officer & Chairman
Karen Zaderej, the President, Chief Executive Officer & Chairman at AxoGen, directs the company's overarching strategy and corporate governance. Overseeing all business operations, Zaderej ensures the successful development and commercialization of AxoGen's surgical solutions for peripheral nerve injuries. This leadership role involves guiding the company's expansion across North America, Europe, and international markets, driving innovation in nerve grafts, connectors, and protectors. By fostering strategic partnerships and maintaining a strong focus on patient outcomes, Karen Zaderej significantly impacts the company's market position and financial performance. The Chairman's responsibilities include setting the long-term vision and ensuring alignment with the board of directors, solidifying AxoGen's commitment to advancing medical technology in nerve repair.
Lindsey Hartley - Chief Financial Officer
Lindsey Hartley, the Chief Financial Officer at AxoGen, manages all financial operations and fiscal strategy. Overseeing budgeting, forecasting, and financial reporting, Hartley ensures the company's financial health and supports its growth initiatives. This critical role involves managing capital allocation, investor relations, and financial compliance across all markets, including North America and Europe. By optimizing financial resources and driving fiscal discipline, Lindsey Hartley directly contributes to the sustainable expansion of AxoGen's surgical solutions portfolio. The Chief Financial Officer's leadership ensures robust financial planning, enabling continued investment in research and development for peripheral nerve repair technologies.
Jens Kemp - Chief Marketing Officer
Jens Kemp, the Chief Marketing Officer at AxoGen, leads all marketing and commercial strategies. Overseeing brand development and market penetration, Kemp drives the adoption of AxoGen's innovative surgical solutions for peripheral nerve injuries across key regions. This role involves shaping market perception and communicating the value of products like the Avance Nerve Graft and AxoGuard Nerve Protector to surgeons and medical facilities. By executing targeted campaigns and fostering strong customer relationships, Jens Kemp significantly enhances market reach and revenue growth. The Chief Marketing Officer's expertise ensures effective positioning of AxoGen's comprehensive portfolio, including diagnostic tools, to meet the evolving needs of the peripheral nerve repair sector.
Ivica Ducic - Chief Medical Officer
Ivica Ducic, the Chief Medical Officer at AxoGen, provides critical medical and scientific leadership. Overseeing clinical strategy and medical affairs, Ducic ensures the efficacy and safety of AxoGen's surgical solutions for peripheral nerve injuries. This role involves guiding clinical research, engaging with the medical community, and translating scientific insights into product development for nerve grafts and protectors. By championing evidence-based medicine and fostering innovation, Ivica Ducic directly supports the advancement of peripheral nerve repair techniques. The Chief Medical Officer's expertise is vital in validating the clinical utility of diagnostic tools like the AcroVal system and driving the company's mission to improve patient outcomes.
Explore Leadership Teams in Manufacturing
Founded in 1919, Ottobock is a German family-owned prosthetics company that provides medical technology solutions. Products include lightweight, active, and power wheelchairs, pediatric rehabilitation products, and seating shell systems. Otto Bock also offers polyurethane foams, foam systems for the automotive industry, and information and communication technology. The company is headquartered in Duderstadt, Germany.
Company Leadership KO
SB
TB
SH
Natus Medical Incorporated provides medical device solutions focusing on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and services used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company is headquartered in Pleasanton, California.
Company Leadership LQ
TA
MO
NR
Lantheus is a healthcare technology company headquartered in Bedford, Massachusetts with additional offices in New Jersey, Canada, and Sweden. Founded in 1956, the company pioneers medical imaging technologies and provides innovative diagnostics, targeted therapeutics, and artificial intelligence solutions for healthcare. Lantheus specializes in developing software and health technologies that empower clinicians to effectively identify, treat, and monitor various diseases. The company maintains a diverse product portfolio focused on enhancing patient care through advanced medical imaging and diagnostic tools. As a publicly traded company since 2019, Lantheus continues to expand its global presence while maintaining its commitment to innovation in healthcare technology.
Company Leadership LL
Patterson Companies, Inc. distributes and sells dental and animal health products in the United States, the United Kingdom, and Canada. It operates through Dental and Animal Health segments. The companys Dental segment offers consumable products, such as infection control, restorative materials, hand instruments, and sterilization products; basic and advanced technology dental equipment; patient education systems; and office forms and stationery. This segment also develops and sells technology solutions, such as practice management software and e-commerce solutions. In addition, it offers a range of related services, including software and design, maintenance and repair, and equipment financing services. The companys Animal Health segment distributes animal health products, such as pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritionals, consumable supplies, equipment, and software to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. This segment also offers a range of value-added services to animal health customers. Patterson Companies, Inc. serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in St. Paul.
Company Leadership TP
LK
DS
Frequently Asked Questions Regarding AxoGen Top Executives and Leadership Team
